DarioHealth Corp.
NASDAQ:DRIO
0.69 (USD) • At close January 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | DarioHealth Corp. |
Symbool | DRIO |
Munteenheid | USD |
Prijs | 0.692 |
Beurswaarde | 26,424,435 |
Dividendpercentage | 0% |
52-weken bereik | 0.631 - 2.6 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Erez Raphael |
Website | https://www.mydario.com |
An error occurred while fetching data.
Over DarioHealth Corp.
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)